• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸地尔硫䓬三层胃滞留型给药系统的制剂、体外评价及变量研究。

Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.

机构信息

Massachusetts College of Pharmacy and Health Sciences (MCPHS) , Boston, MA , USA , and.

出版信息

Drug Dev Ind Pharm. 2014 Mar;40(3):380-9. doi: 10.3109/03639045.2012.763138. Epub 2013 Feb 1.

DOI:10.3109/03639045.2012.763138
PMID:23369093
Abstract

CONTEXT

Tri-layered floating tablets using only one grade of polyethylene oxide (PEO) would enable easy manufacturing, reproducibility and controlled release for highly soluble drugs.

OBJECTIVE

To evaluate the potential of PEO as a sole polymer for the controlled release and to study the effect of formulation variables on release and gastric retention of highly soluble Diltiazem hydrochloride (DTZ).

METHODS

Tablets were compressed with middle layer consisting of drug and polymer while outer layers consisted of polymer with sodium bicarbonate. Design of formulation to obtain 12 h, zero-order release and rapid floatation was done by varying the grades, quantity of PEO and sodium bicarbonate. Dissolution data were fitted in drug release models and swelling/erosion studies were undertaken to verify the drug release mechanism. Effect of formulation variables and tablet surface morphology using scanning electron microscopy were studied.

RESULTS AND DISCUSSION

The optimized formula passed the criteria of USP dissolution test I and exhibited floating lag-time of 3-4 min. Drug release was faster from low molecular weight (MW) PEO as compared to high MW. With an increase in the amount of sodium bicarbonate, faster buoyancy was achieved due to the increased CO2 gas formation. Drug release followed zero-order and gave a good fit to the Korsmeyer-Peppas model, which suggested that drug release was due to diffusion through polymer swelling.

CONCLUSION

Zero-order, controlled release profile with the desired buoyancy can be achieved by using optimum formula quantities of sodium bicarbonate and polymer. The tri-layered system shows promising delivery of DTZ, and possibly other water-soluble drugs.

摘要

背景

仅使用一种等级的聚氧化乙烯(PEO)的三层浮型片剂可实现易制造、重现性和对高溶性药物的控制释放。

目的

评估 PEO 作为控制释放的单一聚合物的潜力,并研究制剂变量对高溶性盐酸地尔硫卓(DTZ)的释放和胃滞留的影响。

方法

用中层药物和聚合物压片,外层由聚合物和碳酸氢钠组成。通过改变 PEO 的等级、数量和碳酸氢钠的数量来设计制剂以获得 12 小时、零级释放和快速漂浮。通过拟合药物释放模型来拟合溶解数据,并进行溶胀/侵蚀研究以验证药物释放机制。研究了制剂变量和片剂表面形态的影响,使用扫描电子显微镜。

结果与讨论

优化的配方通过了 USP 溶解试验 I 的标准,并表现出 3-4 分钟的漂浮滞后时间。与高分子量(MW)PEO 相比,低分子量 PEO 的药物释放更快。随着碳酸氢钠用量的增加,由于 CO2 气体形成的增加,更快的浮力得以实现。药物释放遵循零级,与 Korsmeyer-Peppas 模型拟合良好,表明药物释放是由于聚合物溶胀的扩散所致。

结论

通过使用最佳的碳酸氢钠和聚合物配方量,可以实现零级、控制释放的理想漂浮。三层系统显示出对 DTZ 以及可能的其他水溶性药物有良好的传递效果。

相似文献

1
Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.盐酸地尔硫䓬三层胃滞留型给药系统的制剂、体外评价及变量研究。
Drug Dev Ind Pharm. 2014 Mar;40(3):380-9. doi: 10.3109/03639045.2012.763138. Epub 2013 Feb 1.
2
Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.通过在聚环氧乙烷(PEO)/聚乙二醇(PEG)基质片剂中利用反聚合物实现大量高水溶性盐酸地尔硫䓬的缓释。
Eur J Pharm Biopharm. 2008 Oct;70(2):556-62. doi: 10.1016/j.ejpb.2008.05.032. Epub 2008 Jun 19.
3
Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets.药物溶解度、载药量和聚合物分子量对泊洛沙姆片药物释放的影响。
Drug Dev Ind Pharm. 1998 Jul;24(7):645-51. doi: 10.3109/03639049809082366.
4
Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.盐酸地尔硫䓬口腔漂浮型骨架片制剂的研制与体外评价
AAPS PharmSciTech. 2007 Sep 7;8(3):E73. doi: 10.1208/pt0803073.
5
In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants.应用不同相对分子质量的聚氧化乙烯(PEO)作为阻滞剂的高水溶性药物控释骨架片的体外和体内评价。
Drug Dev Ind Pharm. 2018 Apr;44(4):544-552. doi: 10.1080/03639045.2017.1405429. Epub 2017 Nov 21.
6
Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.盐酸地尔硫䓬和洛伐他汀浮动双层片的设计
PDA J Pharm Sci Technol. 2008 Sep-Oct;62(5):344-52.
7
Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach.采用质量源于设计(QbD)方法研制盐酸尼卡地平胃滞留缓释片。
Drug Dev Ind Pharm. 2018 May;44(5):787-799. doi: 10.1080/03639045.2017.1413111. Epub 2017 Dec 18.
8
Formulation and evaluation of novel coated floating tablets of bergenin and cetirizine dihydrochloride for gastric delivery.新型没食子酰基橙皮苷和盐酸西替利嗪包衣漂浮片的配方与评价及其胃部给药研究。
Drug Dev Ind Pharm. 2012 Oct;38(10):1280-8. doi: 10.3109/03639045.2011.645836. Epub 2011 Dec 30.
9
Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system.含环糊精的聚环氧乙烷片剂用于难溶性药物递送:作为口腔给药系统的潜力
Int J Pharm. 2006 Aug 17;319(1-2):63-70. doi: 10.1016/j.ijpharm.2006.03.031. Epub 2006 Apr 25.
10
Diltiazem Hydrochloride Floating Matrix Tablet: Formulation and Evaluation.盐酸地尔硫䓬漂浮型基质片的制备与评价。
Cardiovasc Hematol Disord Drug Targets. 2024;24(2):110-124. doi: 10.2174/011871529X304157240712072316.

引用本文的文献

1
Development of a Swellable and Floating Gastroretentive Drug Delivery System (GRDDS) of Ciprofloxacin Hydrochloride.盐酸环丙沙星可膨胀漂浮型胃滞留给药系统(GRDDS)的研制
Pharmaceutics. 2023 May 7;15(5):1428. doi: 10.3390/pharmaceutics15051428.
2
Design and In-vitro Evaluation of Sustained Release Floating Tablets of Metformin HCl Based on Effervescence and Swelling.基于泡腾和溶胀的盐酸二甲双胍缓释漂浮片的设计与体外评价
Iran J Pharm Res. 2016 Winter;15(1):53-70.